The United States has dramatically higher healthcare prices than other advanced economies. This is the case for surgical procedures, diagnostic tests, prescription drugs, and almost any other type of healthcare service. Administrative healthcare costs are higher as a share of GDP in the United States than in other countries. These administrative (i.e., nonclinical) costs take several forms: claims processing and payment, prior authorization and eligibility determinations, and quality measurement, among others.

The data are stark: the typical American diet is shortening the lives of many Americans. Diet-related deaths outrank deaths from smoking, and about half of U.S. deaths from heart disease – nearly 900 deaths a day – are linked to poor diet, yet politicians around the country are telling voters they will take on “big pharma.” What we have here is failure to communicate.

Research has shown that 74% of all U.S. adults use the Internet, and 61% have looked for health or medical information on the Internet. Additionally, 49% have accessed a website that provides information about a specific medical condition or problem. Many people get health information from the Internet but are left on their own to determine if it’s credible. This is one area where pharma companies can restore trust and excel.